The sirens' songs of confirmatory sepsis trials

This publication has 17 references indexed in Scilit:

• Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis
  Critical Care Medicine, 1998
• Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
  The Lancet, 1998
• Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
  Critical Care Medicine, 1997
• Anti-inflammatory therapies to treat sepsis and septic shock
  Critical Care Medicine, 1997
• p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock
  JAMA, 1997
• The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis
  New England Journal of Medicine, 1997
• INTERSEPT
  Critical Care Medicine, 1996
• Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome
  JAMA, 1995
• Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial
  Critical Care Medicine, 1994
• Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome
  JAMA, 1994